Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)

Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)

Nibal Saad, Aarati Poudel, Alina Basnet, Ajeet Gajra Internal Medicine Department, Division of Hematology and Oncology, Upstate Cancer Center, SUNY Upstate Medical University, Syracuse, NY, USA Abstract: Adenocarcinoma is the most common type of non-small-cell lung cancer (NSCLC). Adenocarcinoma w...

Full description

Bibliographic Details
Main Authors: Saad N, Poudel A, Basnet A, Gajra A
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:OncoTargets and Therapy
Subjects:
Osimertinib
AZD929
Third generation EGFR TKIs
EGFR T790M
Lung adenocarcinoma
NSCLC
Online Access:https://www.dovepress.com/epidermal-growth-factor-receptor-t790m-mutation-positive-metastatic-no-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/epidermal-growth-factor-receptor-t790m-mutation-positive-metastatic-no-peer-reviewed-article-OTT

Similar Items